Search Results

Fibroblastic reticular cells orchestrate long-term graft survival following recipient treatment with CD40 ligand-targeted costimulatory blockade.

• Authors : Fairchild RL

Subjects: CD40 Ligand* ; Graft Survival*; Mice

• Source: The Journal of clinical investigation [J Clin Invest] 2022 Dec 15; Vol. 132 (24). Date of Electronic Publication: 2022 Dec 15.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice.

• Authors : Zhao J; Transplantation Research Center and.; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Subjects: CD40 Ligand* ; Graft Survival*; Mice

• Source: The Journal of clinical investigation [J Clin Invest] 2022 Dec 15; Vol. 132 (24). Date of Electronic Publication: 2022 Dec 15.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

CD40L modulates transcriptional signatures of neutrophils in the bone marrow associated with development and trafficking.

• Authors : França TT; Department of Immunology, Institute of Biomedical Science, University of São Paulo, São Paulo, São Paulo, Brazil.; Al-Sbiei A

Subjects: Bone Marrow/Bone Marrow/Bone Marrow/*growth & development ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*metabolism

• Source: JCI insight [JCI Insight] 2021 Aug 23; Vol. 6 (16). Date of Electronic Publication: 2021 Aug 23.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.

• Authors : Jabara HH; Division of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.; Brodeur SR

Subjects: Immunoglobulin Class Switching*; B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*drug effects ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*biosynthesis

• Source: The Journal of clinical investigation [J Clin Invest] 2001 Feb; Vol. 107 (3), pp. 371-8.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity.

• Authors : Hänninen A; The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Australia.; Martinez NR

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology ; Immunity, Mucosal/Immunity, Mucosal/Immunity, Mucosal/*immunology ; T-Lymphocytes, Cytotoxic/T-Lymphocytes, Cytotoxic/T-Lymphocytes, Cytotoxic/*immunology

• Source: The Journal of clinical investigation [J Clin Invest] 2002 Jan; Vol. 109 (2), pp. 261-7.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

• Authors : Xu H; Transplantation Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, United States Department of Health and Human Services, Bethesda, Maryland 20892, USA.; Zhang X

Subjects: Blood Platelets/Blood Platelets/Blood Platelets/*immunology ; Blood Platelets/Blood Platelets/Blood Platelets/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*blood

• Source: The Journal of clinical investigation [J Clin Invest] 2006 Mar; Vol. 116 (3), pp. 769-74. Date of Electronic Publication: 2006 Feb 23.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

• Authors : Bour-Jordan H; UCSF Diabetes Center, University of California at San Francisco, San Francisco, California 94143, USA.; Salomon BL

Subjects: CD28 Antigens/CD28 Antigens/CD28 Antigens/*metabolism ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*metabolism

• Source: The Journal of clinical investigation [J Clin Invest] 2004 Oct; Vol. 114 (7), pp. 979-87.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

• Authors : Grammer AC; Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland 20892, USA. ; Slota R

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology

• Source: The Journal of clinical investigation [J Clin Invest] 2003 Nov; Vol. 112 (10), pp. 1506-20.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression

• Authors : Valet, Colin; Magnen, Melia; Qiu, Longhui

• Source: Journal of Clinical Investigation. April 1, 2022, Vol. 132 Issue 7

Record details

Therapeutic CD154 antibody for lupus: promise for the future?

• Authors : Kelsoe G; Department of Immunology, Duke University, Durham, North Carolina 27710, USA.

Subjects: Immunization, Passive*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; CD40 Ligand/CD40 Ligand/CD40 Ligand/*immunology

• Source: The Journal of clinical investigation [J Clin Invest] 2003 Nov; Vol. 112 (10), pp. 1480-2.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details